Harvest Technologies Corporation Selects Osteotech, Inc. as Exclusive U.S. Distributor of its BMAC(TM) (Bone Marrow Aspirate Concentrate) System

PLYMOUTH, Mass.--(BUSINESS WIRE)--Harvest Technologies Corp. (www.harvesttech.com) announced today it has signed an exclusive distribution agreement related to its BMAC™ System in the US for the orthopedic bone regeneration market with Eatontown, N.J.-based Osteotech Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic solutions for regenerative medicine. Harvest’s BMAC (Bone Marrow Aspirate Concentrate) System is a point-of-care device for concentrating a patient’s own (autologous) bone marrow stem cells. The BMAC™ System derives bone marrow aspirate concentrate, which is a rich source of autologous adult stem cells, in just 15 minutes.